Stay updated on Romiplostim & Danazol in ITP Clinical Trial
Sign up to get notified when there's something new on the Romiplostim & Danazol in ITP Clinical Trial page.

Latest updates to the Romiplostim & Danazol in ITP Clinical Trial page
- Check4 days agoChange DetectedThe footer’s site revision identifier changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site footer now identifies the website as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check32 days agoChange DetectedAn NIH-wide notice about its terminology transition appears above the study record, and the site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference1.0%

- Check46 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check67 days agoChange DetectedThe history shows a new release version (v3.7.0) replacing the previous v3.6.6, indicating a backend/UI update to the record history page. This update does not alter study details or data presented on the page.SummaryDifference0.1%

- Check81 days agoChange DetectedThe record history now shows a new revision entry, v3.6.6, replacing the previous v3.6.5. This represents an update to the study record's version history rather than changes to core trial content.SummaryDifference0.1%

Stay in the know with updates to Romiplostim & Danazol in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Romiplostim & Danazol in ITP Clinical Trial page.